Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-κB-mediated induction of XIAP, cIAP2, BCL-X L and survivin

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 833-842

  Momeny, Majid ^a   Zakidizaji, Majid ^b   Ghasemi, Reza ^b   Dehpour, Ahmad R ^b   Rahimi_Balaei, Maryam ^b   Abdolazimi, Yassan ^c   Ghavamzadeh, Ardeshir ^a   Alimoghaddam, Kamran ^a   Ghaffari, Seyed H ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Acute promyelocytic leukemia; Arsenic trioxide; Nuclear factor kappa B; p73

Indexed keywords

ARSENIC TRIOXIDE; ATM PROTEIN; BROXURIDINE; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P21; PROTEIN P73; PROTEIN TIP60; PROTEIN TP53INP1; PROTEIN TYROSINE PHOSPHATASE SHP 2; PROTEIN WNK2; SIRTUIN; SURVIVIN; TETRAZOLIUM; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 77956930205     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9294-9     Document Type: Article

References (58)

1. F Lo Coco D Diverio B Falini A Biondi C Nervi, et al. 1999 Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia Blood 94 12 22 10381493
2. L Di Croce VA Raker M Corsaro F Fazi M Fanelli, et al. 2002 Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor Science 295 1079 1082 10.1126/science.1065173 11834837 (Pubitemid 34132239)
3. HM Pettersson A Pietras M Munksgaard Persson J Karlsson L Johansson, et al. 2009 Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells Mol Cancer Ther 8 160 170 10.1158/1535-7163.MCT-08-0595 19139125
4. J Yu H Qian Y Li Y Wang X Zhang, et al. 2007 Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo Gynecol Oncol 106 400 406 10.1016/j.ygyno.2007.04.016 17512576 (Pubitemid 47096659)
5. M Park J Lee H Kwak C Park H Lee, et al. 2005 Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kB and reactive oxygen species J Cell Biochem 95 955 969 10.1002/jcb.20452 15962302 (Pubitemid 41420143)
6. J Vuky R Yu L Schwartz RJ Motzer 2002 Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma Investig New Drugs 20 327 330 10.1023/A:1016270206374 (Pubitemid 34823761)
7. AA Morales D Gutman KP Lee LH Boise 2008 BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma Blood 111 5152 5162 10.1182/blood-2007-10-116889 18354037
8. T Kanzawa Y Kondo H Ito S Kondo I Germano 2003 Induction of autophagic cell death in malignant glioma cells by arsenic trioxide Cancer Res 63 2103 2108 12727826
9. H Li J He P Ju X Zhong J Liu 2008 Studies on the mechanism of arsenic trioxide-induced apoptosis in HepG2 human hepatocellular carcinoma cells Chin J Clin Oncol 5 22 25 10.1007/s11805-008-0022-6
10. L Zhou JY Chan J Wang K Fung 2008 Anti-proliferation of MDA-MB-231 human breast tumor cells by arsenic trioxide via induction of apoptosis Res J Med Sci 2 236 243
11. WM Cheung PW Chu YL Kwong 2007 Effects of arsenic trioxide on the cellular proliferation, apoptosis and differentiation of human neuroblastoma cells Cancer Lett 246 122 128 10.1016/j.canlet.2006.02.009 16569477 (Pubitemid 44959385)
12. NK Venepalli JK Altman MS Tallman 2006 Evolving role of arsenic trioxide in acute promyelocytic leukemia Clin Leuk 1 36 40 10.3816/CLK.2006.n.006
13. WH Miller Jr HM Schipper JS Lee J Singer S Waxman 2002 Mechanisms of action of arsenic trioxide Cancer Res 62 3893 3903 12124315
14. L Wei K Lai C Chen C Cheng Y Huang, et al. 2005 Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor κB Oncogene 24 390 398 10.1038/sj.onc.1208192 15531921 (Pubitemid 40188587)
15. XH Jiang BC Wong ST Yuen SH Jiang CH Cho, et al. 2001 Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3 Int J Cancer 91 173 179 10.1002/1097-0215(200002)9999: 9999<::AID-IJC1039>3.0.CO;2-D 11146441 (Pubitemid 32041736)
16. Y Akao H Mizoguchi S Kojima T Naoe N Ohishi, et al. 1998 Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein Br J Haematol 102 1055 1060 10.1046/j.1365-2141.1998.00869.x 9734658 (Pubitemid 28410539)
17. WC Chou AL Hawkins JF Barrett CA Griffin CV Dang 2001 Arsenic inhibition of telomerase transcription leads to genetic instability J Clin Investig 108 1541 1547 11714746
18. LH Yih T Lee 2000 Arsenite induces p53 accumulation through an ATM dependent pathway in human fibroblasts Cancer Res 60 6346 6352 11103796
19. G Kroemer H de The′ 1999 Arsenic trioxide, a novel mitochondriotoxic anticancer agent? J Natl Cancer Inst 91 743 745 10.1093/jnci/91.9.743 10328097
20. Z Shen J Shen W Cai C Hong MH Zheng 2000 The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells Int J Mol Med 5 155 158 10639594
21. WG Kaelin Jr 1999 The p53 gene family Oncogene 18 7701 7705 10.1038/sj.onc.1202955 10618710
22. M Kaghad H Bonnet A Yang L Creancier JC Biscan, et al. 1997 Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 90 809 819 10.1016/S0092-8674(00)80540-1 9288759 (Pubitemid 27357971)
23. G Melino V De Laurenzi KH Vousden 2002 p73: friend or foe in tumorigenesis Nat Rev Cancer 2 605 615 10.1038/nrc861 12154353 (Pubitemid 37328927)
24. G Melino F Bernassola M Ranalli K Yee W Xing Zong, et al. 2004 p73 induces apoptosis via puma transactivation and bax mitochondrial translocation J Biol Chem 279 8076 8083 10.1074/jbc.M307469200 14634023 (Pubitemid 38294697)
25. A Yang F McKeon 1997 P63 and P73:P53 mimics, menaces and more Nat Rev Mol Cell Biol 1 199 207 10.1038/35043127
26. R Tomasini M Seux J Nowak C Bontemps A Carrier, et al. 2005 TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity Oncogene 24 8093 8104 16044147
27. T Stiewe BM Putzer 2002 Role of p73 in malignancy: tumor suppressor or oncogene? Cell Death Differ 9 237 245 10.1038/sj.cdd.4400995 11859406 (Pubitemid 34223867)
28. JM Dai ZY Wang DC Sun RX Lin SQ Wang 2007 SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity J Cell Physiol 210 161 166 10.1002/jcp.20831 16998810 (Pubitemid 44904711)
29. A Ruhul Amin VS Thakur RK Paul GS Feng C Qu, et al. 2007 SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG PNAS 104 5419 5424 10.1073/pnas.0700642104 (Pubitemid 47175695)
30. JW Kim PI Song MH Jeong JH An SY Lee, et al. 2008 TIP60 represses transcriptional activity of p73beta via an MDM2-bridged ternary complex J Biol Chem 283 20077 20086 10.1074/jbc.M800161200 18499675
31. V Baud M Karin 2009 Is NFκB a good target for cancer therapy? Hopes and pitfalls Nat Rev Drug Discov 8 33 40 10.1038/nrd2781 19116625
32. Q Deveraux J Reed 1999 IAP family proteins-suppressors of apoptosis Gene Dev 13 239 252 10.1101/gad.13.3.239 9990849
33. M Karin Y Cao F Greten Z Li 2002 NF-κB in cancer: from innocent bystander to major culprit Nat Rev Cancer 2 301 310 10.1038/nrc780 12001991
34. G Bonizzi M Karin 2004 The two NF-kappa activation pathways and their role in innate and adaptive immunity Trends Immunol 25 280 288 10.1016/j.it.2004.03.008 15145317 (Pubitemid 38610351)
35. H Kikuchi T Ozaki K Furuya T Hanamoto M Nakanishi, et al. 2006 NF-κB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway Oncogene 25 7608 7617 10.1038/sj.onc.1209748 16953234 (Pubitemid 44924474)
36. S Moniz F Veríssimo P Matos R Brazão E Silva, et al. 2007 Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2 Oncogene 26 6071 6081 10.1038/sj.onc.1210706 17667937 (Pubitemid 47373812)
37. J Hanai T Mammoto P Seth K Mori SA Karumanchi, et al. 2006 Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells J Biol Chem 280 13641 13647 10.1074/jbc.M413047200
38. J Grosjean-Raillard M Tailler L Ades JL Perfettini C Fabre, et al. 2009 ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia Oncogene 28 1099 1109 10.1038/onc.2008.457 19079347
39. JM Adams S Cory 1998 The Bcl-2 protein family: arbiters of cell survival Science 281 1322 1326 10.1126/science.281.5381.1322 9735050
40. ZX Shen GQ Chen JH Ni XS Li SM Xiong, et al. 1997 Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients Blood 89 3354 3360 9129042
41. TD Schmittgen KJ Livak 2008 Analyzing real-time PCR data by the comparative CT method Nat Protoc 3 1101 1108 10.1038/nprot.2008.73 18546601 (Pubitemid 351818697)
42. A Ghavamzadeh K Alimoghaddam SH Ghaffari S Rostami M Jahani, et al. 2005 Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy Ann Oncol 17 131 134 10.1093/annonc/mdj019 16227315
43. K Alimoghaddam A Shariftabrizi M Tavangar Z Sanaat S Rostami, et al. 2006 Anti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia Leuk Lymphoma 47 81 88 10.1080/10428190500300373 16321832 (Pubitemid 43101729)
44. SH Ghaffari S Rostami D Bashash K Alimoghaddam A Ghavamzadeh 2006 Real-time PCR analysis of PML-RAR in newly diagnosed acute promyelocytic leukaemia patients treated with arsenic trioxide as a front-line therapy Ann Oncol 17 1553 1559 10.1093/annonc/mdl150 16831853 (Pubitemid 44542043)
45. V Mathews B George KM Lakshmi A Viswabandya A Bajel, et al. 2006 Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity Blood 107 2627 2632 10.1182/blood-2005-08-3532 16352810
46. GQ Chen XG Shi W Tang SM Xiong J Zhu, et al. 1997 Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells Blood 89 3345 3353 9129041
47. CJ Sherr JM Roberts 1995 Inhibitors of mammalian G1 cyclin-dependent kinases Genes Dev 9 1149 1163 10.1101/gad.9.10.1149 7758941
48. H Kim M Rafiuddin-Shah H Tu JR Jeffers GP Zambetti, et al. 2006 Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies Nat Cell Biol 8 1348 1358 10.1038/ncb1499 17115033 (Pubitemid 44835109)
49. MS Irwin K Kondo MC Marin LS Cheng WC Hahn, et al. 2003 Chemosensitivity linked to p73 function Cancer Cell 3 403 410 10.1016/S1535-6108(03)00078-3 12726865 (Pubitemid 38340308)
50. M Muscolini R Cianfrocca A Sajeva S Mozzetti G Ferrandina, et al. 2008 Trichostatin A up-regulates p73 and induces bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells Mol Cancer Ther 7 1410 1419 10.1158/1535-7163.MCT-08-0299 18566213
51. X Song HM Sheppard AW Norman X Liu 1999 Mitogen-activated protein kinase is involved in the degradation of p53 protein in the bryostatin-1-induced differentiation of the acute promyelocytic leukemia NB4 cell line J Biol Chem 274 1677 1682 10.1074/jbc.274.3.1677 9880547 (Pubitemid 29057991)
52. R Tomasini A Azizi Samir A Carrier D Isnardon B Cecchinelli, et al. 2003 TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity J Biol Chem 278 37722 37729 10.1074/jbc.M301979200 12851404 (Pubitemid 37175297)
53. M Karin Y Yamamoto QM Wang 2004 The IKK NF-kappa B system: a treasure trove for drug development Nat Rev Drug Discov 3 17 26 10.1038/nrd1279 14708018
54. C Nakanishi M Toi 2005 Nuclear factor-κB inhibitors as sensitizers to anticancer drugs Nat Rev Cancer 5 297 309 10.1038/nrc1588 15803156 (Pubitemid 40488635)
55. Z Tong X Wu JP Kehrer 2003 Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886 Biochem J 372 203 210 10.1042/BJ20021696 12614196 (Pubitemid 36609622)
56. SM Sykes HS Mellert MA Holbert K Li R Marmorstein, et al. 2006 Acetylation of the p53 DNA-binding domain regulates apoptosis induction Mol Cell 24 841 851 10.1016/j.molcel.2006.11.026 17189187 (Pubitemid 44960096)
57. Y Tang J Luo W Zhang W Gu 2006 Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis Mol Cell 24 827 839 10.1016/j.molcel.2006.11.021 17189186 (Pubitemid 44960094)
58. TT Huang SM Wuerzberger-Davis ZH Wu S Miyamoto 2003 Sequential modification of NEMO/IKK gamma by SUMO-1 and ubiquitin mediates NF-kappa B activation by genotoxic stress Cell 115 565 576 10.1016/S0092-8674(03)00895-X 14651848 (Pubitemid 37506045)